Ligand validation:8IRG

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRG_HTG_B_625	70%	40%	0.118	0.935	1.14	1.25	2	3	0	0	100%	1
8IRG_HTG_b_625	64%	38%	0.116	0.914	1.02	1.47	2	5	0	0	100%	1
8IRG_HTG_B_622	29%	31%	0.18	0.836	1.17	1.67	2	6	0	0	100%	1
8IRG_HTG_b_622	26%	22%	0.195	0.838	1.22	2.2	2	8	0	0	100%	1
8IRG_HTG_B_623	13%	41%	0.263	0.8	0.78	1.56	1	1	0	0	100%	1
8IRG_HTG_c_522	8%	38%	0.28	0.762	0.91	1.58	1	3	0	0	100%	1
8IRG_HTG_d_408	7%	38%	0.318	0.801	0.96	1.55	1	2	0	0	84%	0.8421
8IRG_HTG_C_523	6%	42%	0.343	0.776	0.88	1.39	1	2	0	0	100%	1
8IRG_HTG_D_412	4%	37%	0.296	0.684	1.02	1.5	1	1	0	0	84%	0.8421
8IRG_HTG_V_203	3%	56%	0.486	0.913	0.35	1.33	-	1	0	0	58%	0.5789
8IRG_HTG_b_623	1%	27%	0.501	0.703	1.06	1.99	1	4	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.